231 related articles for article (PubMed ID: 9865514)
41. The physiological action of gliclazide: beta-cell function and insulin resistance.
Matthews DR; Hosker JP; Stratton I
Diabetes Res Clin Pract; 1991; 14 Suppl 2():S53-9. PubMed ID: 1794266
[TBL] [Abstract][Full Text] [Related]
42. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide.
Masiello P; Broca C; Gross R; Roye M; Manteghetti M; Hillaire-Buys D; Novelli M; Ribes G
Diabetes; 1998 Feb; 47(2):224-9. PubMed ID: 9519717
[TBL] [Abstract][Full Text] [Related]
43. [Disparity between the effect of glucose and arginine on insulin secretion from the perfused pancreas of non insulin dependent diabetic rats].
Giroix MH; Portha B; Kergoat M; Picon L
C R Seances Acad Sci III; 1981 Nov; 293(10):601-6. PubMed ID: 6800578
[TBL] [Abstract][Full Text] [Related]
44. The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state.
Matthews DR; Boland O
Metabolism; 1997 Dec; 46(12 Suppl 1):5-9. PubMed ID: 9439551
[TBL] [Abstract][Full Text] [Related]
45. Effect of acute administration of gliclazide on the glucose sensitivity of pancreatic B-cells in healthy subjects.
Veneman TF; van Haeften TW; van der Veen EA
Clin Sci (Lond); 1991 Jul; 81(1):101-6. PubMed ID: 1649715
[TBL] [Abstract][Full Text] [Related]
46. Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.
Leahy JL; Bumbalo LM; Chen C
Diabetes; 1994 Feb; 43(2):173-9. PubMed ID: 8288040
[TBL] [Abstract][Full Text] [Related]
47. Effects of galnon, a non-peptide galanin-receptor agonist, on insulin release from rat pancreatic islets.
Quynh NT; Islam MS; Florén A; Bartfai T; Langel U; Ostenson CG
Biochem Biophys Res Commun; 2005 Mar; 328(1):213-20. PubMed ID: 15670772
[TBL] [Abstract][Full Text] [Related]
48. Insulin secretion is stimulated by ethanol extract of Anemarrhena asphodeloides in isolated islet of healthy Wistar and diabetic Goto-Kakizaki Rats.
Hoa NK; Phan DV; Thuan ND; Ostenson CG
Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):520-5. PubMed ID: 15505760
[TBL] [Abstract][Full Text] [Related]
49. Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients.
Riccio A; Lisato G; de Kreutzenberg SV; Marchetto S; Turrin M; Tiengo A; Del Prato S
Metabolism; 1996 Oct; 45(10):1196-202. PubMed ID: 8843172
[TBL] [Abstract][Full Text] [Related]
50. Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice.
Yoshida S; Ohishi T; Matsui T; Tanaka H; Oshima H; Yonetoku Y; Shibasaki M
Biochem Biophys Res Commun; 2010 Nov; 402(2):280-5. PubMed ID: 20937249
[TBL] [Abstract][Full Text] [Related]
51. Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide.
Ohnota H; Koizumi T; Tsutsumi N; Kobayashi M; Inoue S; Sato F
J Pharmacol Exp Ther; 1994 May; 269(2):489-95. PubMed ID: 8182516
[TBL] [Abstract][Full Text] [Related]
52. Both somatostatin and insulin responses to glucose are impaired in the perfused pancreas of the spontaneously noninsulin-dependent diabetic GK (Goto-Kakizaki) rats.
Abdel-Halim SM; Guenifi A; Efendić S; Ostenson CG
Acta Physiol Scand; 1993 Jun; 148(2):219-26. PubMed ID: 8102504
[TBL] [Abstract][Full Text] [Related]
53. Changes in insulin secretion and calcium distribution within B cells induced by gliclazide.
Semino MC; de Gagliardino EE; Gagliardino JJ
Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):787-91. PubMed ID: 3326990
[TBL] [Abstract][Full Text] [Related]
54. Gliclazide mainly affects insulin secretion in second phase of type 2 diabetes mellitus.
Ligtenberg JJ; Reitsma WD; van Haeften TW
Horm Metab Res; 2001 Jun; 33(6):361-4. PubMed ID: 11456286
[TBL] [Abstract][Full Text] [Related]
55. Miglitol (BAY m 1099) treatment of diabetic hypothalamic-dietary obese rats improves islet response to glucose.
Axen KV; Li X; Sclafani A
Obes Res; 1999 Jan; 7(1):83-9. PubMed ID: 10023734
[TBL] [Abstract][Full Text] [Related]
56. Decreased pancreatic islet response to L-leucine in the spontaneously diabetic GK rat: enzymatic, metabolic and secretory data.
Giroix MH; Saulnier C; Portha B
Diabetologia; 1999 Aug; 42(8):965-77. PubMed ID: 10491757
[TBL] [Abstract][Full Text] [Related]
57. Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas.
Gregorio F; Ambrosi F; Filipponi P; Cristallini S; Santeusanio F
J Diabetes Complications; 1994; 8(4):204-12. PubMed ID: 7833495
[TBL] [Abstract][Full Text] [Related]
58. Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells.
Patanè G; Piro S; Rabuazzo AM; Anello M; Vigneri R; Purrello F
Diabetes; 2000 May; 49(5):735-40. PubMed ID: 10905481
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion.
Leng SH; Lu FE; Xu LJ
Acta Pharmacol Sin; 2004 Apr; 25(4):496-502. PubMed ID: 15066220
[TBL] [Abstract][Full Text] [Related]
60. Normalization of impaired glucose tolerance by the short-acting hypoglycemic agent calcium (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionate dihydrate (KAD-1229) in non-insulin-dependent diabetes mellitus rats.
Ohnota H; Koizumi T; Kobayashi M; Momose Y; Sato F
Can J Physiol Pharmacol; 1995 Jan; 73(1):1-6. PubMed ID: 7600439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
